Brief: Mithra Pharmaceuticals FY EBITDA EUR -52.771 Million
08/03/2024 06:34
Mar 8 (Reuters) - Mithra Pharmaceuticals FY net income EUR -173.502 million. * FY EBITDA EUR -52.771 million * FY pretax profit EUR -161.795 million * FY revenue EUR 40.155 million * FY operating income EUR -139.132 million * FY gross profit EUR 18.205 million
Recent news on Mithra Pharmaceuticals SA
See all newsBrief: Mithra Sells Estetra, Neuralis, Specific Assets To Gedeon Richter for EUR 175 Mln
Brief: Mithra Receives Additional EUR 2.5 Million To Advance Monetization
Brief: Mithra Secures Court Protection Measures To Advance Monetization Process
Brief: Mithra Pharmaceuticals Achieves LPR In Estetrol Skin Study
Brief: Mithra Applies To Liege Company Court For A "Transfer Under Judicial Supervision" For Mithra CDMO